Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Donatella Baronciani, Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Akif Yesilipek, Hasan Hashem, Gulyuz Ozturk, Franco Locatelli, Ali Alahmari, Javid Gaziev, Ali Bülent Antmen, O. Alphan Kupesiz, Tunc Fisgin, Giorgio La Nasa, Arjan C. Lankester, Eugene Goussetis, Sandrine Bremathas, Emanuele Angelucci

Blood (2024) 144 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2024-208421

Published: 2024

Journal Articles

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Donatella Baronciani, MD, Maddalena Casale, MD, Lucia De Franceschi, MD, Giovanna Graziadei, MD, Filomena Longo, MD, Raffaella Origa, MD, Valeria Maria Pinto, MD, Paolo Rigano, MD, Monia Marchetti, MD, Antonia Gigante, Emanuele Angelucci, MD, Maria Domenica Cappellini, MD, Achille Iolascon, MD PhD, Antonio Piga, Gian Luca Forni

Blood (2019) 134 (Supplement_1): 972.

https://doi.org/10.1182/blood-2019-128320

Published: 2019

Journal Articles

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Donatella Baronciani, MD, Ariane Boumendil, PhD, Arnaud Dalissier, PhD, Javid Gaziev, Ardeshir Ghavamzadeh, MD, Josu de la Fuente, FRCP, PhD FRCPath, Marco Zecca, MD, Amal Al-Seraihy, MD, O. Alphan Kupesiz, MD, Abdelghani Tbakhi, MD, Gerard Socie, MD PhD, Vassiliki Kitra-Roussou, MD, Arjan Lankester, MD PhD, Gian Luca Forni, MD, Peter Bader, MD PhD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 168.

https://doi.org/10.1182/blood-2018-168

Published: 2018

Journal Articles

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Blood (2015) 126 (23): 1999.

https://doi.org/10.1182/blood.V126.23.1999.1999

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Donatella Baronciani, MD, Cristina Depau, MD, Clara Targhetta, MD, Sara Veronica Usai, MD, Anna Angela Di Tucci, MD, Claudio Romani, MD, Igor Tandurella, PhD, Emanuele Angelucci, MD

Blood (2014) 124 (21): 5905.

https://doi.org/10.1182/blood.V124.21.5905.5905

Published: 2014

Journal Articles

Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation

Donatella Baronciani, MD, Cristina Depau, MD, Clara Targhetta, MD, Anna Angela Di Tucci, MD, Daniele Derudas, MD, Fabio Culurgioni, PhD, Donatella Pulisci, PhD, Igor Tandurella, PhD, Emanuele Angelucci, MD

Blood (2014) 124 (21): 5861.

https://doi.org/10.1182/blood.V124.21.5861.5861

Published: 2014

Journal Articles

Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse

Anna Dodero, MD, Francesco Spina, MD, Franco Narni, Francesca Patriarca, MD, Fabio Benedetti, MD, Donatella Baronciani, MD, Alessandro Rambaldi, Attilio Olivieri, MD, Serena Dalto, MD, Benedetto Bruno, MD, Umberto Vitolo, MD, Paolo Corradini, MD

Blood (2014) 124 (21): 2574.

https://doi.org/10.1182/blood.V124.21.2574.2574

Published: 2014

Journal Articles

Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study

Daniele Derudas, MD, Donatella Baronciani, MD, Cristina Depau, MD, Federica Pilo, MD, Clara Targhetta, MD, Sara Veronica Usai, MD, Giuseppe Longhitano, Daniela Ibba, Emanuele Angelucci

Blood (2013) 122 (21): 2971.

https://doi.org/10.1182/blood.V122.21.2971.2971

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry

Donatella Baronciani, MD, Federica Pilo, MD, Sarah Lyon-Caen, MSc, Ulrike Poetschger, MSc, Giorgio Dini, MD, Christina Peters, MD

Blood (2011) 118 (21): 905.

https://doi.org/10.1182/blood.V118.21.905.905

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up.

Anna Dodero, Francesco Spina, MD, Franco Narni, Francesca Patriarca, Sergio Cortelazzo, MD, Fabio Benedetti, Fabio Ciceri, M.D., Donatella Baronciani, Rosanna Scime', MD, Enrico Pogliani, MD, Alessandro Rambaldi, MD, Francesca Bonifazi, MD, Attilio Olivieri, MD, Benedetto Bruno, Corrado Tarella, Paolo Corradini

Blood (2009) 114 (22): 875.

https://doi.org/10.1182/blood.V114.22.875.875

Published: 2009

Journal Articles

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Blood (2008) 112 (11): 1144.

https://doi.org/10.1182/blood.V112.11.1144.1144

Published: 2008

Journal Articles

Treosulfan - Fludarabine as Ablative Conditioning Regimen for Patients with High Risk Hematologic Malignancies.

Donatella Baronciani, MD, Alessandro Rambaldi, MD, Federica Pilo, MD, Caterina Mico, MD, Simona Deplano, MD, Cristina Depau, MD, Paolo Dessalvi, MD, Emanuele Angelucci, MD

Blood (2006) 108 (11): 5248.

https://doi.org/10.1182/blood.V108.11.5248.5248

Published: 2006

Journal Articles

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Martino Introna, MD, Gianmaria Borleri, Elena Conti, Anna M. Barbui, MD, Raewyn Broady, BSc, Erica Dander, BSc, Giuseppe Gaipa, BSc, Giovanna D’Amico, BSc, Ettore Biagi, MD, Matteo Parma, MD, Enrico Pogliani, MD, Orietta Spinelli, BSc, Donatella Baronciani, MD, Anna Grassi, MD, Josee Golay, PhD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3698.

https://doi.org/10.1182/blood.V108.11.3698.3698

Published: 2006

Journal Articles

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

Donatella Baronciani, MD, Stefania Vaquer, MD, Paola Carta, MD, Eliana Lai, MD

Blood (2004) 104 (11): 3769.

https://doi.org/10.1182/blood.V104.11.3769.3769

Published: 2004

Journal Articles

New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years

Pietro Sodani, David Gaziev, Paola Polchi, Buket Erer, Claudio Giardini, Emanuele Angelucci, Donatella Baronciani, Marco Andreani, Marisa Manna, Sonia Nesci, Barbarella Lucarelli, Reginald A. Clift, Guido Lucarelli

Blood (2004) 104 (4): 1201–1203.

https://doi.org/10.1182/blood-2003-08-2800

Published: 2004

Journal Articles

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation

Emanuele Angelucci, Pietro Muretto, Antonio Nicolucci, Donatella Baronciani, Buket Erer, Javid Gaziev, Marta Ripalti, Pietro Sodani, Silvia Tomassoni, Giuseppe Visani, Guido Lucarelli

Blood (2002) 100 (1): 17–21.

https://doi.org/10.1182/blood.V100.1.17

Published: 2002

Journal Articles

Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation

Emanuele Angelucci, Pietro Muretto, Guido Lucarelli, Marta Ripalti, Donatella Baronciani, Buket Erer, Maria Galimberti, Claudio Giardini, Djavid Gaziev, Paola Polchi, the Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients

Blood (1997) 90 (3): 994–998.

https://doi.org/10.1182/blood.V90.3.994

Published: 1997

NARROW

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation

Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse

Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study

Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry

Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up.

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Treosulfan - Fludarabine as Ablative Conditioning Regimen for Patients with High Risk Hematologic Malignancies.

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation

Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only